Bio4Dreams and ChinaBase have signed a strategic agreement to foster synergies between Europe and China in the Life Sciences sector. The partnership aims to identify, support, and co-finance early-stage startups with technological solutions in biotech, medtech, and digital health, helping them access the Asian market through an impact-driven acceleration ecosystem.

ChinaBase, with offices in Beijing, Hangzhou, Shanghai, and Suzhou, is a key entry platform into the Chinese market for tech startups. Its “Incubation and Investment” program offers a three-stage acceleration path—screening, evaluation, and landing—with direct investment and access to an extensive industrial and financial network. The ecosystem includes investment funds, M&A platforms, research institutes, and industrial partners, focusing on health & medtech, robotics, renewable energy, new materials, and advanced IT.

Thanks to this collaboration, Bio4Dreams startups will benefit from preferred access to the Chinese market, with integrated services, investment opportunities, and connections to local partners. The agreement strengthens tech transfer between the two countries and further positions Bio4Dreams as a key player in Life Sciences innovation.

🌐 Discover other companies in the Bio4Dreams network.